CBT-400

N/A

Report date: 2026/01/20 18:01:48
NME

Base Information

Drug NameCBT-400
Drug Alias NameCBT-400CBT400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCreative Biotherapeutics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A